Nusano and Primo Announce Multi-Isotope Supply Agreement
Nusano and Taiwan-based Primo Biotechnology announced a multi-isotope supply agreement to support radiotheranostic development and targeted cancer therapies.
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →